ACB (Aurora Cannabis) Current Deferred Revenue: $0.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACB Aurora Cannabis Inc ACB
57 GF Score
Price $2.61
GF Value $4.22
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis Current Deferred Revenue?

Aurora Cannabis ACB -2.25% 57 Current Deferred Revenue is $0.9 Mil as of Mar. 2026. GuruFocus rates ACB with a GF Score™ of 57/100 and a GF Value™ of $4.22 (Possible Value Trap). The stock has 2 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Aurora Cannabis's current deferred revenue for the quarter that ended in Mar. 2026 was $0.9 Mil.

Aurora Cannabis Current Deferred Revenue Related Terms

Aurora Cannabis Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Aurora Cannabis's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Cannabis Current Deferred Revenue Chart

Aurora Cannabis Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24 Mar25 Mar26
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.41 3.01 1.25 0.75 0.93

Aurora Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 1.24 1.04 1.39 0.93
ACB
57GF Score
Aurora Cannabis Inc ACB
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.9 Mil mean?
Aurora Cannabis (ACB) has a Current Deferred Revenue of $0.9 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Aurora Cannabis and its competitors.
Is Aurora Cannabis' Current Deferred Revenue too high?
Aurora Cannabis' current Current Deferred Revenue is $0.9 Mil. Overall, Aurora Cannabis has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Current Deferred Revenue compare to ZTS and UTHR?
Aurora Cannabis' Current Deferred Revenue of $0.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Aurora Cannabis and its competitors. Aurora Cannabis's current Current Deferred Revenue is $0.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.22, compared to a current price of $2.61 — trading 38.3% below its estimated fair value. The current Current Deferred Revenue is $0.9 Mil. Aurora Cannabis' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current Current Deferred Revenue is $0.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Cannabis (ACB) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of $2.61 is trading 38.3% below its estimated GF Value™ of $4.22. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for ACB:

  • Current Deferred Revenue: $0.9 Mil
  • GF Value™: $4.22 vs. price of $2.61 (38.3% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
57GF Score

Get the complete analysis for ACB

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.61
Price
$4.22
GF Value